Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIK-HER2 cells in advanced gastric cancer with liver metastasis
NCT02632201Phase 2Unknown
- Sponsor
- Naval Medical University
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 2, randomised trial in gastric cancer (GC) (2 arms), sponsored by Naval Medical University. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02632201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632201.